Download DNB 2016 Dec PAEDIATRICS PAPER 1 Question Paper

Download Diplomate of National Board (DNB) 2016 Dec PAEDIATRICS PAPER 1 Previous Question Paper

FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
DECEMBER 2016
-1-
POSSESSION / USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.
PAEDIATRICS

PAPER ? I
PED/D/16/31/I
Time : 3 hours
Max. Marks : 100

IMPORTANT INSTRUCTIONS


? This question paper consists of 10 questions divided into Part ?A? and Part ?B?, each part
containing 5 questions.
? Answers to questions of Part ?A? and Part ?B? are to be strictly attempted in separate answer
sheet(s) and the main + supplementary answer sheet(s) used for each part must be tagged
separately.
? Answers to questions of Part ?A? attempted in answer sheet(s) of Part ?B? or vice versa shall
not be evaluated.
? Answer sheet(s) of Part ?A? and Part ?B? are not to be tagged together.
? Part ?A? and Part ?B? should be mentioned only on the covering page of the respective answer
sheet(s).
? Attempt all questions in order.
? Each question carries 10 marks.
? Read the question carefully and answer to the point neatly and legibly.
? Do not leave any blank pages between two answers.
? Indicate the question number correctly for the answer in the margin space.
? Answer all the parts of a single question together.
? Start the answer to a question on a fresh page or leave adequate space between two answers.
? Draw table/diagrams/flowcharts wherever appropriate.

PART A

Write short notes on:

1. a) Outline the steps involved in the synthesis of Vitamin D.
b) A seven year old boy presents with deformities suggestive
of rickets. What are the possible causes? Enumerate the
investigations for resistant rickets and treatment of
hypophosphataemic rickets.

3+(3+2+2)
2. Etiopathogenesis and management of septic shock.

5+5
3. a) Measures of central tendency.
b) Odds Ratio.
c) Management of raised intracranial tension.

3+2+5
4. Mechanism of action, therapeutic usage with dosages and
adverse effects in children on:
a) Infliximab.
b) Gamma globulins.
c) Pegylated interferons.

3+4+3
5. Management of status epilepticus in children.

10



P.T.O.
FirstRanker.com - FirstRanker's Choice

This post was last modified on 17 April 2020